Opinion ID: 4151593
Heading Depth: 2
Heading Rank: 2

Heading: Melissa Robinson Watson

Text: Plaintiff Melissa Robinson Watson sought treatment for stress urinary incontinence and received her ObTape implant in May 2004. Watson experienced negative side effects within 25 days of receiving her ObTape implant. It was partially removed two weeks later. After viewing a television commercial regarding transvaginal mesh complications, she filed her lawsuit in January 2013. Watson has suffered from diabetes since she was 17, and before her ObTape implant surgery, her doctor warned her that her diabetes could cause complications. Therefore, when she began to experience erosion and infection, she attributed it to her diabetes and not ObTape. Watson’s doctor did not recall specifically what he told Watson, but he did acknowledge that he wrote “diabetes” in his notes. The district court, in finding that Watson’s claims were time barred, noted that Watson knew the “sling had ‘come apart’ . . . through her vaginal wall” in January 2005 when she underwent a procedure to remove the remaining ObTape. See In re Mentor Corp. Obtape Transobturator Sling Prods. Liab. Litig., 2016 WL 1574071, at  (M.D. Ga. Apr. 19, 2016). The district court reasoned that because 10 Case: 16-10119 Date Filed: 03/09/2017 Page: 11 of 28 Watson knew there was an erosion of the ObTape, she “knew of, strongly suspected, or had enough information to know of a connection between ObTape and at least some of her injuries by the time her doctor excised the ObTape.” Id. at .